AIMPLB to campaign against making Yoga, Surya Namaskar compulsory in schools

Thiruvananthapuram, Apr 16: Seven fresh cases of COVID-19 were reported from Kerala on Thursday, taking the total number of active cases to 147 in the state,even as over 88,000 people are under observation.

On Wednesday, only one positive case had been reported, thelowest in weeks.

While Kannur reported four cases, two were from Kozhikode and one from Kasaragod, Chief Minister Pinarayi Vijayan told reportershere.

Five of those affected had come from abroad, while two have got it through contact with infected people.

Samples of 27 people, including 24 from the worst affected Kasaragod, have turned negative on Thursday.

He said 394 coronavirus cases have so farbeen detected from the state.

Over 80,000 people are under observation, including 532 in various hospitals.

Vijayan said 17,400 samples have been sent for testing of which 16,459 have returned negative.

Mumbai, Mar 3: The country will turn "peaceful" if Prime Minister Narendra Modi's "bhakts" follow him in quitting the social media, the NCP said on Tuesday, taking a dig at the PM over his tweet that was thinking of giving up his social media accounts.

NCP chief spokesperson and Maharashtra minister Nawab Malik also said that Modi's decision will be "in the interest of the country".

His comments came a day after Modi said he is contemplating giving up social media presence.

"This Sunday, thinking of giving up my social media accounts on Facebook, Twitter, Instagram & YouTube. Will keep you all posted," the prime minister said on the micro-blogging site.

Taking a swipe at the prime minister, Malik in a tweet said, "Yesterday, Modi ji gave hint of giving up the social media from Sunday. Some leaders are also talking about giving up (the social media). The country will turn peaceful if all the bhakts (followers) give it up."

"Modi ji's decision will be in the interest of the country. We welcome it, Modi ji take decision," Malik tweeted with the hash tag "ModiQuitsSocialMedia".

Earlier, the Congress took a swipe at the prime minister, with Rahul Gandhi tweeting "Give up hatred, not social media accounts" after tagging Modi's post.

Within minutes of Modi's tweet on Monday, scores of netizens urged him not to quit the various social media platforms as 'No Sir' trended on Twitter.

The prime minister is one of the most-followed world leaders on social media. He has 53.3 million followers on Twitter, 44 million on Facebook and 35.2 millionon Instagram.

The Twitter handle of Prime Minister's Office has 32 million followers.

In September 2019, PM Modi was the third most followed world leader on the microblogging site, behind only US President Donald Trump and his predecessor Barack Obama.

The Prime Minister was the first Indian to cross the 50-million followers mark on Twitter.

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.